Scarica l'app Stockscreener
144.99
0.15%
-0.22
Dopo l'orario di chiusura:
144.99
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GILD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
Wellington Management Group LLP Has $2.84 Billion Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Prudential PLC - MarketBeat
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Oruka Therapeutics (ORKA), Radnet (RDNT) and Gilead Sciences (GILD) - The Globe and Mail
Dodge & Cox Trims Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (NASDAQ:GILD) Upgraded at Wall Street Zen - MarketBeat
Precision Trading with Gilead Sciences Inc. (GILD) Risk Zones - Stock Traders Daily
Gilead Sciences to buy Arcellx in deal valued at $7.8 billion - MSN
Analysts Set Expectations for Gilead Sciences Q1 Earnings - MarketBeat
Martingale Asset Management L P Decreases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Invesco Ltd. Purchases 1,618,453 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
The Zacks Analyst Blog Oracle, T-Mobile, Gilead, and C&F Financial - Yahoo Finance Singapore
How Renewed Wall Street Optimism Around HIV, Oncology And IP Runway At Gilead Sciences (GILD) Has Changed Its Investment Story - finance.yahoo.com
[Form 4] GILEAD SCIENCES, INC. Insider Trading Activity - Stock Titan
Stock Traders Purchase Large Volume of Call Options on Gilead Sciences (NASDAQ:GILD) - MarketBeat
HIV prevention efforts amplified through music at SXSW, Gilead Sciences asserts - Traders Union
Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Momentum And Mixed Fair Value Signals - simplywall.st
Gilead Sciences, Inc. $GILD Stake Boosted by SageView Advisory Group LLC - MarketBeat
Franklin Resources Inc. Decreases Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Bokf Na Raises Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead (NASDAQ:GILD) Institutional Focus Rises In Nasdaq 100 Index - Kalkine Media
HER2-Negative Metastatic Breast Cancer Market Expected to Transform Significantly Through 2034, According to DelveInsight | Genentech, AstraZeneca, Merck Sharp & Dohme LLC, Gilead Sciences, BeiGene - StreetInsider
News | British Land and Royal London sign Gilead at Euston development - CoStar
Gilead’s US$7.8b Arcellx Deal Deepens Cell Therapy Diversification - simplywall.st
Gilead Sciences, Inc. $GILD Shares Sold by Mackenzie Financial Corp - MarketBeat
Magnetar Financial LLC Increases Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
GILD Stock Price, Quote & Chart | GILEAD SCIENCES INC (NASDAQ:GILD) - ChartMill
Gilead at Leerink Conference: Strategic Expansion in Healthcare - Investing.com India
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street’s Latest Biopharma Calls Explained - AOL.com
Jefferies Initiates Coverage on Gilead Sciences (GILD) with 'Buy' Rating | GILD Stock News - GuruFocus
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained - 24/7 Wall St.
What 16 Analyst Ratings Have To Say About Gilead Sciences - Benzinga
Gilead Sciences (NASDAQ:GILD) Now Covered by Analysts at Jefferies Financial Group - MarketBeat
Gilead price boosted by important supportForecast today10-03-2026 - Economies.com
Gilead Sciences, Inc. $GILD Shares Sold by Richard Bernstein Advisors LLC - MarketBeat
Gilead Sciences, Inc. $GILD Stock Position Decreased by Capital Research Global Investors - MarketBeat
Gilead Sciences, Inc. $GILD Holdings Trimmed by Capital World Investors - MarketBeat
Capital International Inc. CA Raises Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Jefferies initiates Gilead Sciences stock with buy rating By Investing.com - Investing.com Canada
Legal & General Group Plc Buys 414,454 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Russell Investments Group Ltd. Sells 49,215 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Fieldview Capital Management LLC Invests $1.91 Million in Gilead Sciences, Inc. $GILD - MarketBeat
GILEAD SCIENCES INC (NASDAQ:GILD): A Durable Dividend Stock for Income Investors - ChartMill
Jefferies initiates Gilead Sciences stock with buy rating - Investing.com
Gilead Sciences, Inc. (NASDAQ:GILD) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Gilead to Acquire Arcellx, Inc. (ACLX) for Up to $7.8 billion - Insider Monkey
Banque Cantonale Vaudoise Has $8.91 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Outperforms Broader Market: What You Need to Know - Yahoo Finance
How Low Can Gilead Sciences Stock Really Go? - Trefis
Swiss National Bank Has $398 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
Schroder Investment Management Group Has $230.08 Million Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Purchased by WINTON GROUP Ltd - MarketBeat
Vinva Investment Management Ltd Increases Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Bought by Kiltearn Partners LLP - MarketBeat
Natixis Advisors LLC Raises Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
B. Metzler seel. Sohn & Co. AG Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Citigroup Maintains Buy on GILD (Gilead Sciences, Inc.) March 2026 - Meyka
Arcellx set to report earnings amid $7.8B Gilead deal - Investing.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Has $2.81 Million Stake in Gilead Sciences, Inc. $GILD - MarketBeat
Parallel Advisors LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Korea Investment CORP Boosts Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Rhenman & Partners Asset Management AB Sells 88,000 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. $GILD Shares Sold by Blair William & Co. IL - MarketBeat
Is It Time To Reassess Gilead Sciences (GILD) After Its Strong Share Price Run - Yahoo Finance
Gilead’s BIC LEN HIV Results Highlight Valuation Gap And Future Potential - Yahoo Finance
Gilead Sciences, Inc. $GILD Shares Purchased by HUB Investment Partners LLC - MarketBeat
Munich Reinsurance Co Stock Corp in Munich Takes $67.50 Million Position in Gilead Sciences, Inc. $GILD - MarketBeat
First Trust Advisors LP Boosts Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Aptus Capital Advisors LLC Raises Position in Gilead Sciences, Inc. $GILD - MarketBeat
GILD Stock Quote Price and Forecast - CNN
Is Gilead Sciences Inc. stock overvalued by current metricsWeekly Trade Review & Low Drawdown Momentum Trade Ideas - Naître et grandir
These 3 Cash Flow Machines Provide Stability in Uncertain Markets - Investing.com
Why Gilead Sciences (GILD) is a Top Value Stock for the Long-Term - Yahoo Finance
BofA reiterates Gilead Sciences stock Buy rating on Yeztugo uptake - Investing.com
Gilead, South Africa in talks for HIV drug production (GILD) - Seeking Alpha
Gilead Sciences, Inc. $GILD Stock Position Lifted by Orion Porfolio Solutions LLC - MarketBeat
Kingsview Wealth Management LLC Trims Stake in Gilead Sciences, Inc. $GILD - MarketBeat
0.16%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):